HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production.

Abstract
Angiotensin type 1 receptor blockers are more effective than other antihypertensive agents in slowing the progression of renal disease. Angiotensin II (Ang II) induces production of NAD(P)H oxidase-dependent superoxide in vascular and mesangial cells, but the direct role of Ang II in glomerular superoxide production remains unknown. Here we examined the effect of Ang II on superoxide production both ex vivo and in vivo. Ang II increased superoxide generation in isolated normal glomeruli in a dose-dependent manner, and co-incubation with olmesartan, an angiotensin type 1 receptor blocker, suppressed such increase. Subtotal nephrectomized rats (Nx, n=8) showed impaired renal function, increased glomerular sclerosis, and significantly high superoxide production in glomeruli. These changes were inhibited in olmesartan-treated (n=8), but not hydralazine-treated (n=8) Nx rats. Oxidative stress and nitrosative stress were observed in Nx glomeruli, as evidenced by increased levels of carbonyl protein and nitrotyrosine formation, respectively. These changes were inhibited by 8-week treatment with olmesartan. The apoptosis observed in Nx glomeruli was also suppressed by olmesartan. Superoxide generation in Nx glomeruli was blocked by an NAD(P)H oxidase inhibitor, diphenylene iodinium. The mRNA expression levels of two NAD(P)H oxidase subunits were increased in Nx, and olmesartan significantly reduced the mRNA expression levels. These results indicate that Ang II directly induced superoxide production through activation of NAD(P)H oxidase, and olmesartan would inhibit superoxide production and oxidative stress independent of its blood pressure-lowering effect. These findings support the notion that superoxide plays a primary role in glomerular injury in chronic kidney disease.
AuthorsSohachi Fujimoto, Minoru Satoh, Hideyuki Horike, Hidekazu Hatta, Yoshisuke Haruna, Shinya Kobayashi, Tamehachi Namikoshi, Sayaka Arakawa, Naruya Tomita, Naoki Kashihara
JournalHypertension research : official journal of the Japanese Society of Hypertension (Hypertens Res) Vol. 31 Issue 2 Pg. 305-13 (Feb 2008) ISSN: 0916-9636 [Print] England
PMID18360051 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Imidazoles
  • RNA, Messenger
  • Tetrazoles
  • Superoxides
  • Angiotensin II
  • Nitric Oxide
  • olmesartan
  • NADPH Oxidases
  • Cyba protein, rat
Topics
  • Angiotensin II (pharmacology)
  • Angiotensin II Type 1 Receptor Blockers (pharmacology)
  • Animals
  • Apoptosis (drug effects)
  • Imidazoles (pharmacology)
  • Kidney Glomerulus (drug effects, metabolism, pathology)
  • Male
  • NADPH Oxidases (genetics)
  • Nephrectomy
  • Nitric Oxide (physiology)
  • Oxidative Stress
  • RNA, Messenger (analysis)
  • Rats
  • Rats, Wistar
  • Superoxides (metabolism)
  • Tetrazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: